Home
Conditions
Hepatitis B

Clinical trial condition

Hepatitis B

Explore clinical trials studying Hepatitis B. Study availability and eligibility vary by location and protocol.

429 public trials 53 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis B trial results

Completed

Clinical Efficacy of ABX203 Therapeutic Vaccine in HBeAg Negative Patients With Chronic Hepatitis B

NCT02249988

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Royal Prince Alfred Hospital Camperdown, Australia

Monash Medical Centre Clayton Clayton, Australia

St Vincent's Hospital Melbourne Fitzroy, Australia

Austin Hospital Heidelberg, Australia

View Trial Details

Completed

Study of Hepalatide(L47) at Phase Ib in Healthy Volunteers

NCT03023787

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: 302 Military Hospital Beijing, China

View Trial Details

Completed

Tenofovir Disoproxil Fumarate vs. Entecavir in Chronic Hepatitis B Patients With Partial Virologic Response to Entecavir

NCT01711567

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis B, +15 more
Locations: Korea University Ansan Hospital Ansan, Gyeonggi-do, South Korea

View Trial Details

Completed

A Study of Pegylated Interferon Alfa-2a and Lamivudine in Patients With HBeAg-Negative Chronic Hepatitis B Virus (HBV)

NCT01095835

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Bari, Apulia, Italy

Castellana Grotte, Apulia, Italy

San Giovanni Rotondo, Apulia, Italy

Caserta, Campania, Italy

View all 22 locations

View Trial Details

Completed

ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B

NCT00661076

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Ankara, Turkey (Türkiye)

Ankara, Turkey (Türkiye)

Ankara, Turkey (Türkiye)

Ankara, Turkey (Türkiye)

View Trial Details

Completed

An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HBeAg-Positive or HBeAg-Negative Chronic Hepatitis B

NCT01734018

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Berlin, Germany

Leipzig, Germany

View Trial Details

Completed

A Follow-Up Study of Patients With HBeAg Positive Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML22265

NCT01645969

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Changsha, China

Fuzhou, China

Guangzhou, China

Wuhan, China

View Trial Details

Completed

A Study of PEGASYS (Peginterferon Alfa-2a [40KD]) in Patients With Hepatitis B e Antigen (HBeAg)-Negative Chronic Hepatitis B Virus (HBV)

NCT02570191

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Pleven, Bulgaria

Plovdiv, Bulgaria

Sofia, Bulgaria

Sofia, Bulgaria

View Trial Details

Completed

A Study of Peginterferon Alfa-2a (Pegasys) in Participants With Hepatitis B E-Antigen (HBeAg)-Positive Chronic Hepatitis B Virus (HBV)

NCT02604823

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Beijing, China

Guangzhou, China

Shanghai, China

View Trial Details

Completed

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

NCT00614471

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Beijing, China

Hangzhou, China

Shanghai, China

Shanghai, China

View Trial Details

Hepatitis B

Hepatitis B trial results

Related conditions